We are live on ! Find out more
PRVL

Prevail Therapeutics Inc. Common Stock
PRVL

Delisted

PRVL was delisted on the 21st of January, 2021.

Name Holding Trade Value Shares
Change
Change in
Stake
O
1
OrbiMed
New York
$219M
RCM
2
RA Capital Management
Massachusetts
$53.2M
EC
3
EcoR1 Capital
California
$35.6M -$1.84M -144,250 -6%
Citadel Advisors
4
Citadel Advisors
Florida
$18.5M +$1.28M +100,003 +9%
BC
5
Boxer Capital
California
$17.8M
Fidelity Investments
6
Fidelity Investments
Massachusetts
$13.8M
BlackRock
7
BlackRock
New York
$11.3M +$3.41M +267,040 +60%
OFM
8
Omega Fund Management
Massachusetts
$10.6M -$13 -1 -0%
BI
9
BVF Inc
California
$10.4M
Adage Capital Partners
10
Adage Capital Partners
Massachusetts
$7.85M -$204K -16,000 -3%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$5.8M +$4.67M +366,324 New
Vanguard Group
12
Vanguard Group
Pennsylvania
$4.84M +$911K +71,431 +30%
Bank of America
13
Bank of America
North Carolina
$4.39M +$470K +36,821 +15%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$3.38M +$43.6K +3,419 +2%
State Street
15
State Street
Massachusetts
$1.66M +$546K +42,767 +69%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$1.56M +$218K +17,099 +21%
Northern Trust
17
Northern Trust
Illinois
$1.29M -$28.9K -2,269 -3%
UBS Group
18
UBS Group
Switzerland
$1.22M +$979K +76,764 New
DCM
19
DAFNA Capital Management
California
$1.19M
AS
20
Altshuler Shaham
Israel
$799K
Squarepoint
21
Squarepoint
New York
$319K +$257K +20,154 New
CI
22
Clal Insurance
Israel
$292K -$3.67M -287,378 -98%
Nuveen
23
Nuveen
North Carolina
$282K -$83.9K -6,576 -27%
Charles Schwab
24
Charles Schwab
California
$248K
Goldman Sachs
25
Goldman Sachs
New York
$247K +$199K +15,579 New